BREAST CANCER SELECTIVE THERAPEUTIC DEVELOPMENT: LEAD OPTIMIZATION OF A SMALL-MOLECULE INHIBITOR OF THE BREAST CANCER SELECTIVE HUB PROTEIN CAPCNA

Regents Of The University Of California At Riverside

Investigators